Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 279Generated: October 23, 2026

4-Bromophenol → 4-Morpholinophenol

https://huagongshe.com/en/reaction/279

Reaction equation

Participants

RoleNameHCIDCharge
Reactant4-BromophenolHCID 7808—
ReactantMorpholineHCID 8083—
ReagentSodium t-butoxideHCID 23676156—
CatalystBis(dibenzylideneacetone)palladiumHCID 9811564—
Catalyst2-Dicyclohexylphosphino-2',4',6'-triisoprophylbiphenylHCID 11155794—
SolventTolueneHCID 1140—
Product4-MorpholinophenolHCID 8051031.25%

Reaction Conditions

Temperature100 °C

Reaction Steps

4-Bromophenol (865 mg, 5 mmol), Tris(dibenzylideneacetone)dipalladium(0) (229 mg, 0.25 mmol), 2-Dicyclohexylphosphino-2',4',6'-tri-iso-propyl-1,1'-biphenyl (238 mg, 0.50 mmol), Morpholine (0.437 mL, 5.00 mmol) and sodium tert-butoxide (1009 mg, 10.50 mmol) were stirred in toluene (5 mL) overnight at 100 °C. The mixture was allowed to cool to ambient temperature. Ethylacetate was added and the mixture was washed with aqueous NaHCO3 (satd.) and water. The organic phase was separated, dried over MgSO4, filtered and the solvent removed by rotary evaporation. The crude product was added to a silica gel column and was eluted with 0-2 % MeOH in DCM. The collected fraction were combined and the solvent was removed by rotary evaporation. 1H NMR in CDCl3 is consistent with desired product MS (m+1) = 180. HPLC Peak RT = 2.55 minutes is product. Purity = 96%.

Provenance & Evidence

Source dataset750 AstraZeneca ELN dataset
ORD IDord-c3c3446fa521406ab3b5349b3ab1378a
Source note750 AstraZeneca ELN dataset